The Lung Team at the Christie is currently recruiting in a study for untreated patients with stage 4 NSCLC harbouring a KRAS G12C Mutations and pd-l1 expression of 50% or above (PI @DrColinLindsay).
If interested, please email [email protected]@BTOGORG
It was a busy day on Monday for our Media Technologist, Olivia. She began filming the #PatientExperience of diagnosis and treatment through #COVID19 for our upcoming #SoOLung2020 study day.
Secure your place today:
https://t.co/btwjfwjQwJ
Osimertinib NICE approved for 1L EGFR mutant NSCLC. Fantastic news for the EGFR population. Well done to all those involved. @team_lung @philruss3@caliraf@MFT_Genomics@AstraZeneca@NICEComms
https://t.co/Cym4j4V8tH
The Manchester Bee is such a symbol of the community strength of Manchester - I'm proud to be a Manchester worker bee this weekend @TheChristieNHS keeping the spirit and industry of Manchester alive whilst others #StayHomeSaveLifes 🐝🐝🐝 @AndyBurnhamGM
photo @samyarwood89
#COVID19 Encouraging data of hydroxychloroquine from a small N=24 trial by Prof. Didier Raoult in France
75% patients turned #coronavirus negative after 600mg hydroxychloroquine treatment for 6 days vs only 10% in control group
https://t.co/4CXOpPpIaa
https://t.co/MFrw3LiD2V
Here at The Christie, we’re following guidance issued by @PHE_uk in order to manage and contain the spread of COVID-19.
To protect our patients we are restricting visitors to the site.
Please visit our website for more information
👉 https://t.co/5D6oY5ifS3